Search Results - jens+wrammert

4 Results Sort By:
SARS-CoV-2 Neutralizing Human Monoclonal Antibodies
­ Application Monoclonal antibodies to SARS-CoV2 for use in COVID-19 diagnostics and therapeutics. Key Benefits Demonstrably neutralizing, important for therapeutic mAbs. Most bind both RBG and stalk portion of spike protein, useful in case SARS-CoV2 strains develop variation in RBD. Market Summary Coronavirus (COVID-19) is an infectious...
Published: 10/17/2024   |   Inventor(s): Jens Wrammert, Carl Davis, Mehul Suthar, Robert Kauffman
Keywords(s): Antibody, COVID19, Microbiology/Infectious Diseases
Category(s): TechPub Algolia > Diagnostics, TechPub Algolia > Therapeutics
Serological Test for SARS-CoV-2
­ Application Clinical assay for detecting SARS-CoV-2 neutralizing antibodies. Key Benefits Highly specific and sensitive. Fewer false positives than commercially available tests. Market Summary SARS-CoV-2 is currently causing a devastating pandemic and there is a pressing need to understand the dynamics, specificity, and neutralizing...
Published: 7/30/2024   |   Inventor(s): Rafi Ahmed, Mehul Suthar, John Roback, Jens Wrammert, Robert Kauffman
Keywords(s): Assay, COVID19, Microbiology/Infectious Diseases, Vaccine
Category(s): TechPub Algolia > Diagnostics, TechPub Algolia > Drug Discovery, TechPub Algolia > Micro and Nanotechnology
Antibodies for Zika and Dengue Viruses
Applications ELISA Western Blot Immunohistochemistry Specificity Human monoclonal Technical Summary Zika Virus (ZIKV) is a mosquito borne filovirus responsible for a 2016-2017 epidemic in North and South America. ZIKV nonstructural protein 1 (NS1) is a pathogenicity factor implicated in virus replication, host interaction and immune invasion....
Published: 7/30/2024   |   Inventor(s): Jens Wrammert, Mark Mulligan
Keywords(s): Antibody, Microbiology/Infectious Diseases
Category(s): TechPub Algolia > Diagnostics, TechPub Algolia > Research Tools
Cross-Reactive Antibodies Against Influenza Virus
Application Human recombinant antibodies against influenza, including H1N1, for the development of diagnostic tests and universal flu vaccines. Key Benefits Broadly protective antibodies against multiple influenza strains Market Summary Influenza spreads swiftly and globally, causing some of the most severe pandemics in the last century. Each year,...
Published: 7/30/2024   |   Inventor(s): Rafi Ahmed, Patrick Wilson, Jens Wrammert
Keywords(s): Antibody, Microbiology/Infectious Diseases
Category(s): TechPub Algolia > Diagnostics, TechPub Algolia > Research Tools, TechPub Algolia > Therapeutics